Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.
Teva and Alvotech Announce FDA Approval of Interchangeability for Selarsdi (ustekinumab-aekn) with Stelara (ustekinumab)
PARSIPPANY, N.J. & REYKJAVÍK, Iceland, May 05, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries...
Combined Flu, SARS-CoV-2 Vaccine as Effective as Individual Vaccines for Older Adults
mRNA-1083 vaccine is noninferior and induces higher immune responses than recommended influenza and COVID-19 vaccines against several influenza strains...
Three New Color Food Additives From Natural Sources Approved by FDA
The U.S. Food and Drug Administration announced the approval of three new color additives, a move that will provide manufacturers with a wider range of...
FDA Warns of Possible Bacteria Contamination of Tattoo Inks
Two tattoo inks have tested positive for harmful bacteria and the use of them could lead to serious infections, according to an alert from the U.S. Food...
No Negative Psychological Impact Seen for Disclosing Aβ Status
Disclosure of amyloid-β (Aβ) status seems not have a negative psychological impact, according to a study published online May 7 in Alzheimer's...
Thinking About a Tattoo? FDA Warns These Inks Could Be Dangerous
FRIDAY, May 9, 2025 — The U.S. Food and Drug Administration (FDA) is warning consumers and tattoo artists that two tattoo inks have tested positive...
Trump Taps Wellness Influencer Casey Means for Surgeon General
FRIDAY, May 9, 2025 — President Donald Trump has chosen Dr. Casey Means, a wellness influencer and health tech entrepreneur, to be his nominee...
Some Cancers Increasing in People Under 50, New Report Shows
FRIDAY, May 9, 2025 — More young adults in the U.S. are being diagnosed with cancer, and researchers are trying to figure out why. A new government...
Women With Autoimmune Disease At Greater Risk For Heart-Related Death
FRIDAY, May 9, 2025 — Women with common autoimmune inflammatory diseases are more likely than men to die from heart disease, a new study says. Women...
Boehringer Ingelheim Starts Phase II Study of its Potential First-in-Class Oral Compound as a Treatment for Geographic Atrophy
Boehringer Ingelheim today announces the start of the JADE Phase II clinical study (NCT06769048), investigating the efficacy and safety of BI 1584862 as...
Vanda Announces Bysanti NDA Filing; FDA Decision Expected in Early 2026
Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) informed Vanda that the New Drug Application...
Alterity Therapeutics Granted U.S. FDA Fast Track Designation for ATH434 to Treat Multiple System Atrophy
MELBOURNE, AUSTRALIA AND SAN FRANCISCO, USA – 5 May 2025 Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the...
Body Mass Index (BMI): What It Tells You — And What It Doesn’t
SUNDAY, May 4, 2025 — Body Mass Index, or BMI, is a number that reflects the relationship between your height and weight. It's widely used in healthcare...
Recently Added
Recently added consumer and prescribing information: Miudella, Opdivo Qvantig, Alyftrek, Crenessity, Ensacove, Steqeyma, Yesintek, Revuforj, Danziten, Aucatzyl
For Consumers
- Cerner Multum Drug Information
- Micromedex Advanced Consumer
- Natural Product Information for the Consumer
For Professionals
- FDA Professional Information
- Professional Patient Advice
- ASHP Monographs (AHFS DI)
- Micromedex CareNotes
- Natural Product Information
For Researchers
Latest FDA New Drug Approvals
- Imaavy Imaavy (nipocalimab-aahu) is a neonatal Fc receptor (FcRn) blocker used for the treatment of generalized myasthenia gravis.
- Atzumi Atzumi (dihydroergotamine mesylate) is a nasal powder formulation of the ergotamine derivative dihydroergotamine mesylate for the acute...
- Zevaskyn Zevaskyn (prademagene zamikeracel) is an autologous, cell sheet-based gene therapy for the treatment of recessive dystrophic epidermolysis bullosa.
Drugs in Development (Not yet approved)
- Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil tentatively approved for the treatment of pulmonary arterial...